Glenview Capital to push CVS Health to make changes - Wall Street Journal

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LMT
8. USO
9. TLT
10. AMZN

Go back to Glenview Capital to push CVS Health to make changes - Wall Street Journal

Morgan Stanley Reiterates Overweight Rating on CVS Health (CVS)

October 2, 2024 6:56 AM EDT

Morgan Stanley analyst Erin Wright reiterated an Overweight rating and $65.00 price target on CVS Health (NYSE: CVS).

The analyst comments "Latest Hypothetical SOTP Suggests Upside, But Variables Remain: In light of a recent Reuters report (here) noting that the CVS Board may be considering potential options to break up CVS retail and insurance businesses, we detail our latest SOTP analysis, including key assumptions below. CVS declined to... More

Leerink Partners Reiterates Market Perform Rating on CVS Health (CVS)

October 1, 2024 6:28 AM EDT

Leerink Partners analyst Michael Cherny reiterated a Market Perform rating on CVS Health (NYSE: CVS).

The analyst comments "Bottom Line: Following our initial note highlighting the potential of CVS evaluating strategic alternatives including a break-up of the company (Initial CVS note; WSJ report) we wanted to include some quick views on the potential plusses and potential minuses of a breakup. This isn't meant to be comprehensive and is intentionally short form given the fluidity of the reported situation. But we thought it was important to highlight how this... More

Evercore ISI Reiterates Outperform Rating on CVS Health (CVS)

October 1, 2024 5:54 AM EDT

Evercore ISI analyst Elizabeth Anderson reiterated an Outperform rating and $62.00 price target on CVS Health (NYSE: CVS).

The analyst comments "What happened? After the market close today, Reuters reported that CVS is exploring options, including a potential break-up of the company to... More